Our previous study showed that PD-L1 expression on tumor cells was not associated with the overall survival rate of patients with EOCs, although stromal PD-L1 expression was an independent prognostic factor, especially in ovarian serous carcinoma [11]. This evidence concerns the gene CD274 and ovarian serous carcinoma.